Family Planning Ahead

Dartmouth-Hitchcock Medical Center1 个研究点分布在 1 个国家目标入组 41 人2018年3月22日

适应症Contraception Pregnancy Related

概览

阶段: 不适用
干预措施: 未指定
疾病 / 适应症: Contraception
发起方: Dartmouth-Hitchcock Medical Center
入组人数: 41
试验地点: 1
主要终点: Perceived support in decision-making
状态: 终止
最后更新: 7年前

概览研究者入排标准结局指标研究点相似试验

概览

简要总结

Family Planning Ahead is a study that aims to improve decision-making about postpartum contraception. Family Planning Ahead will test two different strategies: a patient decision aid and a patient information leaflet.

注册库

clinicaltrials.gov

开始日期

2018年3月22日

结束日期

2018年8月23日

最后更新

7年前

研究类型

Interventional

研究设计

Parallel

性别

Female

研究者

发起方

Dartmouth-Hitchcock Medical Center

责任方

Principal Investigator

主要研究者

Rachel L. Thompson

Assistant Professor, The Dartmouth Institute

Dartmouth-Hitchcock Medical Center

入排标准

入选标准

•Currently pregnant
•Between 28 and 38 weeks' gestation at the time of enrollment
•Estimated due date in March, April, May, or June 2018
•15 years or older
•Can read and write English
•Live in the United States
•Share a valid email address for study purposes
•Exclusion Criteria
•Not currently pregnant
•Less than 28 weeks' or more than 38 weeks' gestation at the time of enrollment

排除标准

未提供

结局指标

主要结局

Perceived support in decision-making

时间窗: T2 (Approximately 7-11 weeks after self-reported estimated due date)

The extent to which the person feels they received adequate support and advice without pressure to make a decision about postpartum contraceptive methods, measured using adapted versions of the Support subscale of the Decisional Conflict Scale (O'Connor, 1993).

次要结局

Values clarity(T0 (immediately following study enrollment); T1 (one week following study enrollment))
Perceptions of being informed(T0 (immediately following study enrollment); T1 (one week following study enrollment))
Trust in health professional(s)(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Pressure to use a certain contraceptive method(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Likelihood of recommending the intervention to a friend(T1 (one week following study enrollment))
Perceived utility of the intervention(T1 (one week following study enrollment))
Concordance between preferred and actual decision-making involvement (partner): Concordant vs. discordant(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Values concordance of intended contraceptive method(s)(T0 (immediately following study enrollment); T1 (one week following study enrollment))
Interpersonal quality of family planning care(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Shared decision-making(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Decisional uncertainty(T0 (immediately following study enrollment); T1 (one week following study enrollment))
Intended contraceptive method(s): Most or moderately effective vs. other(T0 (immediately following study enrollment); T1 (one week following study enrollment))
Intended contraceptive method(s): Method vs. no method or unsure(T0 (immediately following study enrollment); T1 (one week following study enrollment))
Time pressure in decision-making(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Contraceptive method(s) prescribed in first 3 days: Most or moderately effective vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Decision self-efficacy(T0 (immediately following study enrollment); T1 (one week following study enrollment))
Intended timing of contraceptive method(s) initiation: Not unsure vs. unsure(T0 (immediately following study enrollment); T1 (one week following study enrollment))
Concordance between preferred and actual decision-making involvement (self): Concordant vs. discordant(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Values concordance of contraceptive method(s) used(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Contraceptive method(s) prescribed in first 60 days: LARC vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Contraceptive method(s) used: LARC vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Timing of decision about contraceptive method(s): During pregnancy vs. since giving birth(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Likelihood of reviewing the intervention in the future(T1 (one week following study enrollment))
Effective decision(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Intended contraceptive method(s): LARC vs. other(T0 (immediately following study enrollment); T1 (one week following study enrollment))
Concordance between preferred and actual decision-making involvement (health professional(s)): Concordant vs. discordant(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Contraceptive method(s) prescribed in first 60 days: Most or moderately effective vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Contraceptive method(s) used: Method vs. no method(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Contraceptive method(s) prescribed in first 3 days: LARC vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))
Contraceptive method(s) used: Most or moderately effective vs. other(T2 (Approximately 7-11 weeks after self-reported estimated due date))